Skip to content
HowShorted

bluebird bio, Inc. short interest in 2022

In 2022, bluebird bio, Inc.'s disclosed short interest ran from 9.83% of shares outstanding on 14 Jan 2022 to 22.00% on 30 Dec 2022, a change of +12.17 percentage points. The year's high was 29.45% on 30 Sep 2022 and its low 9.83% on 14 Jan 2022, averaging 19.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.15 days on 14 Apr 2022. Full history: bluebird bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for bluebird bio, Inc. in 2022

2022 in figures

Start of year
9.83% (14 Jan 2022)
End of year
22.00% (30 Dec 2022)
Change
+12.17 pp
High
29.45% (30 Sep 2022)
Low
9.83% (14 Jan 2022)
Average
19.64%
Highest days to cover
7.15 (14 Apr 2022)
SEC filings marked
9

Every report in 2022

bluebird bio, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20229.83%4.86results (8-K)
31 Jan 20229.92%2.01
15 Feb 202210.25%3.68
28 Feb 202210.24%4.24
15 Mar 202211.18%2.8410-K filed, results (8-K)
31 Mar 202216.07%3.93
14 Apr 202215.96%7.15
29 Apr 202217.01%5.41
13 May 202217.32%4.6610-Q filed, results (8-K)
31 May 202217.64%5.42
15 Jun 202224.52%1.48
30 Jun 202221.12%1.00
15 Jul 202218.77%1.91
29 Jul 202221.26%4.55
15 Aug 202221.35%1.8910-Q filed, results (8-K)
31 Aug 202225.60%1.88
15 Sep 202226.06%2.98
30 Sep 202229.45%1.89
14 Oct 202229.10%4.53
31 Oct 202229.23%6.26
15 Nov 202223.24%4.0310-Q filed, results (8-K)
30 Nov 202222.04%6.75
15 Dec 202222.26%6.23
30 Dec 202222.00%5.79

See also: bluebird bio, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.